NCT01438749View on ClinicalTrials.gov

A Study of The Abuse Liability Potential of RO4917838 in Recreational Drug Users

PHASE1CompletedINTERVENTIONAL
Enrollment

177

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Healthy Volunteer
Interventions
DRUG

Placebo

Single dose

DRUG

RO4917838

Single doses (3 dose levels)

DRUG

diazepam

Single dose

Trial Locations (1)

84106

Salt Lake City

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01438749 - A Study of The Abuse Liability Potential of RO4917838 in Recreational Drug Users | Biotech Hunter | Biotech Hunter